A Transgenic Rat for Noninvasive Assessment of Chondrogenic Activity in vivo
用于体内软骨形成活性无创评估的转基因大鼠
基本信息
- 批准号:9217577
- 负责人:
- 金额:$ 17.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-02-07 至 2017-09-15
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAnimal ModelBiological AssayBioluminescenceBone MarrowBone Marrow Stem CellCartilageCell Differentiation processCellsChondrocytesChondrogenesisChronicClinicalCollagen Type IICommunitiesDefectDegenerative polyarthritisDetectionDevelopmentElementsEngineeringEvaluationFirefly LuciferasesFracture HealingFutureGenesGenetic EngineeringImplantInjectableInjuryIntra-Articular InjectionsJointsKneeKnock-outKnowledgeLacZ GenesLuciferasesMeasuresMeniscus structure of jointMesenchymal Stem CellsModelingMolecularMusOrthopedicsOsteogenesisOutcomePain MeasurementPathway interactionsProcessRattusReactionRegenerative MedicineRegulationRenilla LuciferasesReporterReportingResearchResearch PriorityResourcesRodent ModelSourceSpecific qualifier valueSpecificityStem cellsSynovial MembraneSynovial jointTamoxifenTechniquesTestingTissuesTransgenic OrganismsTransplantationWorkarticular cartilagebasebone cellbone imagingcartilage repairgenetically modified cellsgenome editinghealingimaging platformimprovedin vivoin vivo Modelinnovationjoint functionjoint injuryloss of functionmouse genomemouse modelnext generationnon-invasive imagingnovel therapeuticsosteochondral tissuepostnatalpreclinical evaluationpreventpublic health relevancerat genomerecombinaseregenerativerepairedskeletalskeletal tissuesoft tissuestemstem cell biologysubchondral bonetissue repairtooltreatment strategy
项目摘要
DESCRIPTION (provided by applicant): Rodent models of joint injury are vital for the development of next-generation treatment strategies to prevent post-traumatic osteoarthritis (PTOA). In recent decades, the application of genetic engineering techniques to the well-characterized genome of mice has resulted in the revolutionary development of transgenic and knockout strains. While these mouse models are now a fundamental tool in orthopaedic research, similar rat models have been lagging. However, an improving knowledge of the rat genome combined with continued advances in genome editing now make transgenic rat development more practical. There are important differences between rats and mice that make the latter species preferred for initial testing of novel therapeutics in vivo. For example, the ra is routinely used for evaluating new stem cell-based strategies to stimulate osteochondral tissue repair, whereas mouse joints are too small for this purpose. Rat models of injury have been advanced by the ability to noninvasively image stem cells genetically engineered to express molecular reporters. Among the available reporters, the luciferases catalyze intense bioluminescent reactions that can be measured quantitatively with established imaging platforms. If rats were genetically engineered to express a luciferase specifically within cells committed to the chondrogenic lineage, this would allow noninvasive evaluation of endogenous chondroprogenitor cell (CPC) differentiation. CPC chondrogenesis within cartilage and meniscal defects is an important bottleneck to repair, and this rat model would help test strategies to overcome this bottleneck. The first project aim will be to generate a transgenic rat in which Firefly luciferase (FLuc) and LacZ are expressed specifically by cells committed to the chondrogenic lineage, while Renilla luciferase (RLuc) and inducible CreERT2 recombinase are expressed constitutively by all cells. Exploiting the postnatal specificity of type II collagen expression within cells of the chondrogenic lineage, we will use regulatory sequences from the Col2a1 gene for controlling FLuc and LacZ expression. Once the dual- lucifase trasngenic rat has been made, the second project aim will be to demonstrate its utility using two in vivo models of joint injury: (i) osteochondral defects made in wild type rats receiving transgenic CPCs, and (ii) a meniscectomy model of PTOA in wild type rats, injecting transgenic CPCs. For these initial studies, mesenchymal stem cells from bone marrow and synovium will be compared. Once the transgenic rat has been characterized, it will be made available as a resource to the orthopaedic research community. When combined with existing bioluminescence assays and imaging platforms, this strain will permit sensitive, quantitative measuring of pro-chondrogenic activity i studies of not only joint injury but also endochondral bone formation (e.g., fracture healing). The
engineering of tamoxifen-inducible CreERT2 into this rat will allow it to be crossed with future LoxP rats for gain and loss of function studies, greatly broadening its application and, ultimately accelerating orthopaedic research.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ryan Michael Porter其他文献
Examining the Effects of Quercetin on Phenotypic Characteristics of Human Mesenchymal Stem Cells
- DOI:
10.1007/s12195-025-00849-y - 发表时间:
2025-05-30 - 期刊:
- 影响因子:5.000
- 作者:
Thomas Needy;David Heinrichs;Vitali Maldonado;Ryan Michael Porter;Hanna Jensen;C. Lowry Barnes;Rebekah Margaret Samsonraj - 通讯作者:
Rebekah Margaret Samsonraj
Ryan Michael Porter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ryan Michael Porter', 18)}}的其他基金
Extracellular vesicles as therapeutic vehicles for chondroprotection
细胞外囊泡作为软骨保护的治疗载体
- 批准号:
10117408 - 财政年份:2019
- 资助金额:
$ 17.22万 - 项目类别:
Extracellular vesicles as therapeutic vehicles for chondroprotection
细胞外囊泡作为软骨保护的治疗载体
- 批准号:
10357781 - 财政年份:2018
- 资助金额:
$ 17.22万 - 项目类别:
Extracellular vesicles as therapeutic vehicles for chondroprotection
细胞外囊泡作为软骨保护的治疗载体
- 批准号:
10268960 - 财政年份:2018
- 资助金额:
$ 17.22万 - 项目类别:
A Transgenic Rat for Noninvasive Assessment of Chondrogenic Activity in vivo
用于体内软骨形成活性无创评估的转基因大鼠
- 批准号:
9592522 - 财政年份:2017
- 资助金额:
$ 17.22万 - 项目类别:
A Transgenic Rat for Noninvasive Assessment of Chondrogenic Activity in vivo
用于体内软骨形成活性无创评估的转基因大鼠
- 批准号:
9015521 - 财政年份:2016
- 资助金额:
$ 17.22万 - 项目类别:
Facilitating cartilage regeneration by heterogeneous progenitor cells
通过异质祖细胞促进软骨再生
- 批准号:
8330976 - 财政年份:2009
- 资助金额:
$ 17.22万 - 项目类别:
Facilitating cartilage regeneration by heterogeneous progenitor cells
通过异质祖细胞促进软骨再生
- 批准号:
8530951 - 财政年份:2009
- 资助金额:
$ 17.22万 - 项目类别:
Facilitating cartilage regeneration by heterogeneous progenitor cells
通过异质祖细胞促进软骨再生
- 批准号:
7643619 - 财政年份:2009
- 资助金额:
$ 17.22万 - 项目类别:
Facilitating cartilage regeneration by heterogeneous progenitor cells
通过异质祖细胞促进软骨再生
- 批准号:
8333207 - 财政年份:2009
- 资助金额:
$ 17.22万 - 项目类别:
Gene-activated Bone Marrow Plugs for Cartilage Repair
用于软骨修复的基因激活骨髓塞
- 批准号:
7159066 - 财政年份:2006
- 资助金额:
$ 17.22万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 17.22万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 17.22万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 17.22万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 17.22万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 17.22万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 17.22万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 17.22万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 17.22万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 17.22万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 17.22万 - 项目类别:
Research Grant